J. Githanga

发表

Wilms tumor survival in Kenya.

H. Lovvorn, Flora Ukoli, J. O'Neill, 2013, Journal of pediatric surgery.

Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months

M. Åstrand, B. Ogutu, A. Inati, 2021, Pediatric blood & cancer.

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study

M. Åstrand, A. Michelson, A. Himmelmann, 2022, Blood.

Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).

A. Michelson, M. Heeney, J. Kanter, 2019, Contemporary clinical trials.

The management of children with Kaposi sarcoma in resource limited settings

J. Orem, P. Hesseling, T. Israels, 2013, Pediatric blood & cancer.

Risk factors for abandonment of Wilms tumor therapy in Kenya

M. Shrubsole, H. Lovvorn, F. Njuguna, 2015, Pediatric blood & cancer.

Design and Implementation of the Retinoblastoma Collaborative Laboratory

E. Dimba, H. Dimaras, A. Limo, 2016, Ocular Oncology and Pathology.

Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study

C. Abnet, S. Dawsey, C. Giffen, 2016, The American Journal of Gastroenterology.

Prevalence of esophageal squamous dysplasia in relatives of patients with esophageal cancer in Southwestern Kenya.

P. Albert, C. Abnet, S. Dawsey, 2022, Cancer epidemiology.